Monomeric Amyloid-Beta Regulates Brain Development by Inhibiting Microglial Inflammatory Activation
Monomeric amyloid-beta activates an anti-inflammatory signaling pathway in microglia mediated by APP and heterotrimeric G proteins, which suppresses microglial cytokine expression and matrix metalloproteinase activity, thereby ensuring proper assembly of the cerebral cortex during development.